|View printer-friendly version|
|March 26, 2003 4:34 p.m.|
|Teva Announces Tentative Approval of Metformin HCl Extended-Release Tablets|
Jerusalem, Israel, March 26, 2003 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has granted tentative approval of the company's ANDA for Metformin HCl Extended-Release Tablets, 500 mg. The brand product's annual sales are approximately $410 million.